When COVID hit London in mid-March 2020, Dr Ramzi Khamis found himself almost ovenight co-leading Imperial College's cardiology response to the pandemic. He had to find solutions to enable his teams to cope with adapting the service to deal with an influx of patients sick with the little-understood virus, whilst also maintaining the usual business of seeing people with heart attacks. Continue reading →

Among patients with acute coronary syndromes, malnutrition seems common and is tied to increases in mortality and cardiovascular events, according to a new Spanish analysis. To identify malnourished patients is a chance for clinical cardiologists to improve the prognosis of patients with acute coronary syndrome, lead author Sergio Raposeiras Roubn, MD, PhD (Hospital lvaro Cunqueiro, Pontevedra, Spain), told TCTMD in an email. This is very important in cardiac rehabilitation units; those units should include nutritional intervention programs Continue reading →

Dr. Rafael Rivero, M.D., Global Head of Medical Affairs at MSI, said: "The importance ofMyoStraincannotbe understated because of the test's immense clinical value and ability to quantify intramyocardial dysfunction across 48 segments of the heart. In a six-heartbeat MRI scan, MyoStrain arms physicians with novel clinical information about a patient's heart health." Dr Continue reading →

Levels of a set of circulating biomarkers indicative of extracellular matrix homeostasis were found to be elevated in patients with heart failure (HF) with preserved ejection fraction (EF; HFpEF), and were reduced after treatment with sacubitril/valsartan, according to results of a multicenter, double-blind, randomized clinical trial published in the Journal of the American College of Cardiology. In this study, data from the Prospective Comparison of ARNI With ARB Global Outcomes in HF With Preserved Ejection Fraction trial, in which patients from North America, Europe, Asia, and Latin America with chronic HF with HFpEF were randomly assigned 1:1 to receive sacubitril/valsartan or valsartan alone, were analyzed. Eligible participants (n=1135) were > 50 years, had signs and symptoms of HF, New York Heart Association functional classes II to IV, left ventricular ejection fraction (LVEF) 45%, and structural heart disease Continue reading →

Source: ThinkStock August 11, 2020 -Small hospitals across the country are turning to telehealth to expand their treatment options and give patients access to specialists they might otherwise have to travel long distances to see. These services not only improve care for patients, but help the hospital to keep that care in the community. Such is the case with the Beauregard Health System, an acute care hospital in rural DeRidder, LA Continue reading →

August 10, 2020 08:02 ET | Source: Research Dive New York, USA, Aug. 10, 2020 (GLOBE NEWSWIRE) -- What is In Vitro Diagnostics (IVD)? In vitro diagnostics (IVD) are tests performed on samples like tissues or blood of the patient to detect disorders or other conditions Continue reading →